Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
129,668,560
Number of holders
253
Total 13F shares, excl. options
125,764,461
Shares change
-1,727,699
Total reported value, excl. options
$1,744,349,407
Value change
-$25,594,791
Put/Call ratio
18.37%
Number of buys
96
Number of sells
-124
Price
$13.87

Significant Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q2 2024

292 filings reported holding NEO - NEOGENOMICS INC - Common Stock, par value $0.001 per share as of Q2 2024.
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) has 253 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 125,764,461 shares of 129,668,560 outstanding shares and own 96.99% of the company stock.
Largest 10 shareholders include BlackRock Inc. (19,670,074 shares), VANGUARD GROUP INC (14,121,490 shares), BROWN ADVISORY INC (8,771,361 shares), T. Rowe Price Investment Management, Inc. (6,730,283 shares), JANUS HENDERSON GROUP PLC (6,619,336 shares), STATE STREET CORP (4,878,133 shares), Greenhouse Funds LLLP (4,784,941 shares), SCHRODER INVESTMENT MANAGEMENT GROUP (4,198,632 shares), First Light Asset Management, LLC (3,782,561 shares), and DIMENSIONAL FUND ADVISORS LP (3,324,624 shares).
This table shows the top 253 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.